Abstract
We investigated 143 patients with various classes of liver disease and 120 healthy subjects for serological markers of hepatitis C and B viruses. We found a prevalence rate of 37.1% of anti-HCV markers in patients with liver disease (cases), and 4.2% and in the control group. HBsAg was detected in 33.6% of cases and 13.3% of the controls. Anti-HCV and HBsAg were detected in 7.7% of cases but were not detected in the controls. Anti-HCV, HBsAg, anti-HBe and anti-HDV were detected in three patients. Serum protein electrophoresis results showed elevated gammaglobulin and low albumin in patients positive for anti-HCV who had liver disease.
MeSH terms
-
Acute Disease
-
Adolescent
-
Adult
-
Age Distribution
-
Biomarkers / blood
-
Blood Protein Electrophoresis
-
Case-Control Studies
-
Child
-
Chronic Disease
-
Female
-
Hepatitis B / blood
-
Hepatitis B / complications*
-
Hepatitis B / epidemiology
-
Hepatitis B / immunology
-
Hepatitis B Surface Antigens / blood
-
Hepatitis B e Antigens / blood
-
Hepatitis C / blood
-
Hepatitis C / complications*
-
Hepatitis C / epidemiology
-
Hepatitis C / immunology
-
Hepatitis C Antibodies / blood
-
Hepatitis D / blood
-
Hepatitis D / complications
-
Hepatitis D / epidemiology
-
Hepatitis D / immunology
-
Hospitals, University
-
Humans
-
Liver Diseases / epidemiology
-
Liver Diseases / virology*
-
Male
-
Middle Aged
-
Population Surveillance
-
Seroepidemiologic Studies
-
Sex Distribution
-
Yemen / epidemiology
Substances
-
Biomarkers
-
Hepatitis B Surface Antigens
-
Hepatitis B e Antigens
-
Hepatitis C Antibodies